COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 139: Articles 1381-1390  | Next

Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults with hybrid immunity against COVID-19: a multicenter, partially randomized, platform trial in China
Jia, S., Liu, Y., He, Q., Pan, H., Liang, Z., Zhou, J., Pan, Y., Liu, S., Wu, J., Yang, K., Zhang, X., Zhao, Y., Li, S., Zhang, L., Chen, L., Yao, A., Lu, M., Mao, Q., Zhu, F., Li, J.
10.1101/2024.09.14.24313671 — Posted: 2024-09-15
Modeling the effects of COVID-19 mobility disruptions on RSV transmission in Seattle, Washington
Srinivas Duddu, A., Elgamal, I., Camacho-Mateu, J., Holubowska, O., Rella, S. A., Bents, S. J., Viboud, C., Hansen, C. L., Pullano, G., Perofsky, A. C.
10.1101/2024.09.13.24313667 — Posted: 2024-09-15
Variant Evolution Graph: Can We Infer How SARS-CoV-2 Variants are Evolving?
Das, B., Heath, L. S.
10.1101/2024.09.13.612805 — Posted: 2024-09-15
Comparative Effectiveness of the mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults With Underlying Medical Conditions: A Systematic Literature Review and Pairwise Meta-Analysis Using GRADE
Wang, X., Pahwa, A., Bausch-Jurken, M. T., Chitkara, A., Sharma, P., Malmenas, M., Vats, S., Gordon Whitfield, M., Zhi Hua Lai, K., Dasari, P., Gupta, R., Nassim, M., Van de Velde, N., Green, N., Beck, E.
10.1101/2024.09.13.24313632 — Posted: 2024-09-14
SARS-CoV-2 protein ORF3a induces Atg8ylation of lysosomal membranes
Ajnar, D., Sarkar, A., Riyaz, S., Menon, P., Dutta, D., Asati, P., Sharma, P., Pydi, S. P., Kumar, S.
10.1101/2024.09.12.612614 — Posted: 2024-09-14
Ongoing evolution of Middle East Respiratory Syndrome Coronavirus, Kingdom of Saudi Arabia, 2023-2024
Hassan, A. M., Mühlemann, B., Al-Subhi, T. L., Rodon, J., El-Kafrawy, S. A., Memish, Z., Melchert, J., Bleicker, T., Mauno, T., Perlman, S., Zumla, A., Jones, T. C., Müller, M. A., Corman, V. M., Drosten, C., Azhar, E. I.
10.1101/2024.09.12.612455 — Posted: 2024-09-14
G-CSF and IL-6 drive myeloid dysregulation during severe viral infection
Kajihara, K., Yan, D., Seim, G., Little-Hooy, H., Kang, J., Chen, C., De Simone, M., Delemarre, T., Darmanis, S., Shivram, H., Bauer, R., Rosenberger, C. M., Kapadia, S., Xu, M., Reyes, M.
10.1101/2024.09.12.612764 — Posted: 2024-09-14
Forecasting local surges in COVID-19 hospitalizations through adaptive decision tree classifiers
Murray-Watson, R. E., Bilinski, A., Yaesoubi, R.
10.1101/2024.09.12.24313570 — Posted: 2024-09-13
Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study
Al Rahmoun, M., Sabate-Elabbadi, A., Guillemot, D., Brun-Buisson, C., Watier, L.
10.1101/2024.09.11.24311990 — Posted: 2024-09-13
How young people experienced Long COVID services: a qualitative analysis.
Taylor, O., Treneman-Evans, G., Riley, M., Bond-Kendall, J., Pike, K.
10.1101/2024.09.12.24312643 — Posted: 2024-09-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).